Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
ReviewMorpholino antisense oligomers: the case for an RNase H-independent structural type
Section snippets
RNase H cleavage: origins of the broad acceptance of S-DNAs
A key requirement for effective antisense oligos is that they remain intact for many hours in the extracellular medium and within cells. The methylphosphonate-linked DNA analogs developed by Miller and Ts’o in the late 1970s constituted a major advance in the emerging antisense field by providing the first antisense type having good stability in biological systems [1]. However, concerns subsequently developed that methylphosphonates might be inadequate for many antisense applications,
Limitations of S-DNAs
With continued study of S-DNAs it is now widely recognized that their good efficacy and targeting versatility are counterbalanced by a variety of disadvantages.
Efficacy
A key property of the RNase H-competent S-DNAs which led to their broad adoption by the antisense community was their greatly increased efficacy (likely a consequence of their RNase H competency) relative to methylphosphonates. However, since then at least two RNase H-independent types (PNAs [16] and morpholinos [17] shown in Fig. 1) have been developed which often match or exceed the efficacy of S-DNAs in a cell-free translation system when said oligos are targeted to sequences in the region
Predictable targeting
A problem which has plagued antisense research with S-DNAs is the difficulty of predicting which antisense sequences will be effective in cells. As a consequence, multiple S-DNAs may need to be prepared and empirically tested in order to identify an oligo with good in-cell activity [23], [24]. Further, when one does find an effective oligo through such an empirical search it is not unusual to find that it is targeted in a region of the RNA, such as the 3′ untranslated region [25], which one
Positive test system
A long standing limitation in antisense research has been that the available test systems rely on down-regulation. This includes such a crude measure as inhibition of cell growth, as well as assays for inhibition of the synthesis or activity of a particular protein, and assays for degradation of a particular RNA (useful only with RNase H-competent oligos). The difficulty in these negative test systems is that a variety of non-antisense effects can also lead to down-regulation or what appears to
Delivery into cultured cells
In the 1980s a number of antisense experiments with cultured cells suggested that antisense oligos readily enter cultured animal cells and have good access to their targeted RNAs therein. These early results led scientists in the antisense field to believe that antisense oligos, and particularly non-ionic types, could readily diffuse across cell membranes. However, by the early 1990s reality reared its ugly head in the form of a number of careful experiments whose results indicated that neither
References (58)
- et al.
Destabilization of messenger RNA/complementary DNA duplexes by the elongating 80S ribosome
J. Biol. Chem.
(1986) - et al.
Oligodeoxynucleotide phosphorothioate stability in subcellular extracts, culture media, sera, and cerebrospinal fluid
J. Biochem. Biophys. Methods
(1990) - et al.
Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression
J. Biol. Chem.
(1993) - et al.
In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA
J. Biol. Chem.
(1996) - et al.
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms
J. Biol. Chem.
(1991) - et al.
Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression
J. Biol. Chem.
(1993) Developing antisense oligonucleotides from the laboratory to clinical trials
Drug Discov. Today
(1996)- et al.
Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles
Cell
(1982) - et al.
The third helix of the Antennapedia homeodomain translocates through biological membranes
J. Biol. Chem.
(1994) - et al.
Nonionic nucleic acid analogues: synthesis and characterization of dideoxyribonucleoside methylphosphonates
Biochemistry
(1979)
Hybridization arrest of globin synthesis in a rabbit reticulocyte lysate and in rabbit reticulocytes by oligodeoxyribonucleoside methylphosphonates
Biochemistry
Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides
J. Am. Chem. Soc.
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides
Nucleic Acids Res.
The use of single-stranded DNA and RNase H to promote quantitative ‘hybrid arrest of translation’ of mRNA/DNA hybrids in reticulocyte lysate cell-free translations
Nucleic Acids Res.
A specificity comparison of four antisense types: morpholino, 2′O-methyl RNA, DNA, and phosphorothioate DNA
Antisense Nucleic Acid Drug Dev.
Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?
Antisense Res. Dev.
CpG motifs in bacterial DNA trigger direct B cell activation
Nature
Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells
Antisense Res. Dev.
Rapid induction of Jak2 and Sp1 in T cells by phosphorothioate oligonucleotides
Antisense Nucleic Acid Drug Dev.
Regulation of viral expression of human immuno-deficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells
Proc. Natl. Acad. Sci. USA
Morpholino antisense oligomers: design, preparation and properties
Antisense Nucleic Acid Drug Dev.
Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems
Antisense Nucleic Acid Drug Dev.
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides
Proc. Natl. Acad. Sci. USA
Selecting effective antisense reagents on combinatorial oligonucleotide arrays
Nat. Biotechnol.
Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
Nat. Biotechnol.
Cited by (586)
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges
2024, Cell Chemical Biologyβ-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models
2023, Journal of Controlled ReleaseDevelopment of nucleic acid medicines based on chemical technology
2023, Advanced Drug Delivery ReviewsThe novel K<inf>V</inf>7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit
2023, Biomedicine and PharmacotherapyTherapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamics
2023, Molecular Therapy Nucleic AcidsAltering gene expression using antisense oligonucleotide therapy for hearing loss
2022, Hearing Research